Reuters logo
BRIEF-European Commission approves expanded use of Mimpara for the treatment of secondary hyperparathyroidism in children with end-stage renal disease on dialysis
2017年8月31日 / 晚上8点10分 / 3 个月前

BRIEF-European Commission approves expanded use of Mimpara for the treatment of secondary hyperparathyroidism in children with end-stage renal disease on dialysis

Aug 31 (Reuters) - Amgen Inc

* European commission approves expanded use of Mimpara (cinacalcet) for the treatment of secondary hyperparathyroidism in children with end-stage renal disease on dialysis

* Amgen inc - ‍EC approved Mimpara based on studies Amgen began in 2007 to assess use of Mimpara in pediatric patients with secondary HPT​ Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below